Internet Archive Scholar

SMAD1 promoter hypermethylation and lack of SMAD1 expression in Hodgkin lymphoma: a potential target for hypomethylating drug therapy

Magdalena M Gerlach, Anna Stelling-Germani, Cheuk Ting Wu, Sebastian Newrzela, Claudia Döring, Visar Vela, Anne Müller, Sylvia Hartmann, Alexandar Tzankov
2020

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (1.9 MB)
https://web.archive.org/web/20201210014217/https://www.zora.uzh.ch/id/eprint/192097/1/Gerlach_et_al_Haematologica.pdf

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL. The file type is application/pdf.

2020). SMAD1 promoter hypermethylation and lack of SMAD1 expression in Hodgkin lymphoma: a potential target for hypomethylating drug therapy. Haematologica:Epub ahead of print. . SMAD1 promoter hypermethylation and lack of SMAD1 expression in Hodgkin lymphoma: a potential target for hypomethylating drug therapy.
doi:10.5167/uzh-192097 fatcat:hl5eeoo3gbapxl4qcmw7y5nj5q
Citation

Magdalena M Gerlach, Anna Stelling-Germani, Cheuk Ting Wu, Sebastian Newrzela, Claudia Döring, Visar Vela, Anne Müller, Sylvia Hartmann, Alexandar Tzankov. "SMAD1 promoter hypermethylation and lack of SMAD1 expression in Hodgkin lymphoma: a potential target for hypomethylating drug therapy." (2020)